Troy Cox

Troy M.
Cox is currently Chairman at SOPHiA GENETICS SA since 2020, Vice Chairman at LetsGetChecked, Inc. since 2020, Independent Director at Standard BioTools, Inc. since 2024, Director at Zymeworks BC, Inc. since 2019, Director at Massachusetts Biotechnology Council since 2018, Director at Dream Foundation since 2015, and Director at Biosplice Therapeutics, Inc. since 2021.
Former roles include President & Chief Executive Officer at Foundation Medicine, Inc. from 2018 to 2019, Independent Director at CM Life Sciences II, Inc. in 2021, Independent Director at SomaLogic, Inc. from 2023 to 2024, Independent Director at Zymeworks, Inc. from 2019 to 2025, SVP-BioOncology Sales, Marketing & US Commercial at Genentech, Inc. from 2010 to 2017, Principal at Schering-Plough Corp., Principal at Aventis, Inc., President-CNS Operations at UCB SA, Senior Vice President at Sanofi-Aventis U.S.
LLC from 2001 to 2006, and President-CNS operations at UCB Biopharma SRL.
Education includes an MBA from the University of Missouri and undergraduate studies at the University of Kentucky.